Under pathological conditions such as multiple sclerosis (MS) and its respective experimental model in rodents (Experimental Autoimmune Encephalomyelitis, EAE), CD44 has immunomodulatory properties and protects from the disruption of the BBB [43]. The gene discussed is CD44; the disease is myeloid sarcoma.